ALL is the most common childhood cancer, and cases are rising. Find out why this trend is paired with a remarkable 90% survival rate, and what public health action is needed next.
Nearly a third of families with children receiving chemotherapy for acute lymphoblastic leukemia (ALL)—the most common ...
Highlights in acute lymphoblastic leukemia (ALL), presented at the American Society of Hematology (ASH) 2024 Annual Meeting and Exposition, include studies on pediatric and adult disease, as discussed ...
Hosted on MSN
Duration of overweight or obesity during treatment linked to worse outcomes in pediatric leukemia patients
New research on children diagnosed with acute lymphoblastic leukemia (ALL) shows that the longer a patient's body mass index (BMI) falls within the overweight/obese category during treatment, the ...
Acute lymphoblastic leukemia (ALL) may be confused with different types of hematological conditions. Confusion of ALL diagnosis with acute myeloid leukemia (AML), hairy cell leukemia and malignant ...
Supportive care aims to ensure that patients with acute lymphoblastic leukemia (ALL) derive the most benefit from ALL therapy despite the intensive treatments they undergo. Supportive care should be ...
In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after prior treatment, experienced comparable outcomes whether they received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback